Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2018

View Archived Issues

HM-81422 as a novel treatment option for patients with HCC with altered FGF19/FGFR4 pathway

Novel BET bromodomain inhibitor TG-1601 a clinical candidate

Bill & Melinda Gates Foundation grant supports Recursion's expansion into malaria

Procella and Smartwise establish cardiovascular collaboration with AstraZeneca

Novel formulation of ribaxamase protects the gut microbiome

Delcath initiates pivotal trial of melphalan in intrahepatic cholangiocarcinoma

Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides

EMA gives positive scientific advice on development plan and regulatory pathway for AM-111

CARB-X supports Melinta's development of pyrrolocytosine compounds

Human papillomavirus cancer vaccine utilizes CD11b-targeting nanobodies

Pfizer nominates final hepatic targets under collaboration with Wave Life Sciences

E.U. funding supports development of The Cell Factory's second-generation EV drug for stroke

FDA approves Darzalex with VMP for newly diagnosed multiple myeloma

QuANTUM-R study of quizartinib in FLT3-ITD-mutated AML meets primary endpoint

FDA approves Myrbetriq in combination with solifenacin for overactive bladder

Aptose exercises option to license CrystalGenomics' CG-806

New trial explores use of AMO-01 in Phelan-McDermid syndrome

Takeda and Shire reach agreement on recommended offer for Shire

INTEREST study of Traumakine in ARDS does not meet primary efficacy composite endpoint

Polaris Pharmaceuticals creates new ADI-TRAIL fusion protein with antitumor activity

Carna collaborates with Evotec to accelerate development of CB-1763

FDA grants fast track designation to Debio-1347

Valeant Pharmaceuticals International to change name to Bausch Health Companies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...